Chagas disease surgery: Difference between revisions
Category |
Hudakarman (talk | contribs) |
||
| Line 5: | Line 5: | ||
Surgery is not indicated in the treatment of Chagas disease. | Surgery is not indicated in the treatment of Chagas disease. | ||
==Surgery== | ==Surgery== | ||
<br /> | |||
Heart transplantation is not considered a contraindication for heart transplantation. | |||
Despite the risk of T cruzi reactivation after transplantation and immunosuppression, universal “prophylactic” antitrypanosomal therapy is not recommended. Quantitative T cruzi PCR provides sufficient sensitivity to detect a reactivation before complications such as allograft dysfunction develop. Benznidazole has been the drug of choice for the treatment of T cruzi reactivations. Because treatment does not result in a cure of chronic T cruzi infection, patients remain vulnerable to new episodes of reactivation, and lifelong T cruzi monitoring is required. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 22:11, 14 February 2020
|
Chagas disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chagas disease surgery On the Web |
|
American Roentgen Ray Society Images of Chagas disease surgery |
|
Risk calculators and risk factors for Chagas disease surgery |
Overview
Surgery is not indicated in the treatment of Chagas disease.
Surgery
Heart transplantation is not considered a contraindication for heart transplantation.
Despite the risk of T cruzi reactivation after transplantation and immunosuppression, universal “prophylactic” antitrypanosomal therapy is not recommended. Quantitative T cruzi PCR provides sufficient sensitivity to detect a reactivation before complications such as allograft dysfunction develop. Benznidazole has been the drug of choice for the treatment of T cruzi reactivations. Because treatment does not result in a cure of chronic T cruzi infection, patients remain vulnerable to new episodes of reactivation, and lifelong T cruzi monitoring is required.